6:15 PM
 | 
Dec 18, 2012
 |  BC Extra  |  Company News

GSK submits NDA for COPD product

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and partner Theravance Inc. (NASDAQ:THRX) said GSK submitted an NDA to FDA for Anoro Ellipta umeclidinium bromide/vilanterol for maintenance bronchodilator...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >